267
Views
16
CrossRef citations to date
0
Altmetric
Review

Potential drug interactions associated with treatments for Type 2 diabetes and its comorbidities: a clinical pharmacology review

&
Pages 31-42 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sreymom Yim, Byoung Hoon You, Hee-Sung Chae, Young-Won Chin, Hojun Kim, Han Seok Choi & Young Hee Choi. (2017) Multidrug and toxin extrusion protein 1-mediated interaction of metformin and Scutellariae radix in rats. Xenobiotica 47:11, pages 998-1007.
Read now
Ranjeet Prasad Dash, R. Jayachandra Babu & Nuggehally R. Srinivas. (2017) Comparative pharmacokinetics of three SGLT-2 inhibitors sergliflozin, remogliflozin and ertugliflozin: an overview. Xenobiotica 47:11, pages 1015-1026.
Read now
Xueying Tan & Jingbo Hu. (2016) Combination therapy for type 2 diabetes: dapagliflozin plus metformin. Expert Opinion on Pharmacotherapy 17:1, pages 117-126.
Read now

Articles from other publishers (12)

Adel E. Berbari & Najla A. Daouk. 2023. Blood Pressure Disorders in Diabetes Mellitus. Blood Pressure Disorders in Diabetes Mellitus 437 448 .
Beere Nagaraju & KV Anilkumar. (2021) Pharmacodynamic and pharmacokinetic interaction of losartan with glimepiride-metformin combination in rats and rabbits. Indian Journal of Pharmacology 53:6, pages 465.
Crossref
Adriana Orellana-Paucar & Daniela Vintimilla-Rojas. (2020) Interactions of clinical relevance associated with concurrent administration of prescription drug and food or medicinal plants: a systematic review protocol. Systematic Reviews 9:1.
Crossref
Dejan Z. Aleksic, Slobodan M. Jankovic, Milos N. Mlosavljevic, Gordana L. Toncev, Svetlana D. Miletic Drakulic & Srdjan M. Stefanovic. (2019) Potential drug-drug interactions in acute ischemic stroke patients at the Neurological Intensive Care Unit. Open Medicine 14:1, pages 813-826.
Crossref
Kristen J. Bubb, Rebecca H. Ritchie & Gemma A. Figtree. (2019) Modified redox signaling in vasculature after chronic infusion of the insulin receptor antagonist, S961. Microcirculation 26:2, pages e12501.
Crossref
Michael Ruberson Ribeiro da Silva, Leonardo Maurício Diniz, Jéssica Barreto Ribeiro dos Santos, Edna Afonso Reis, Adriana Rodrigues da Mata, Vânia Eloisa de Araújo, Juliana Álvares & Francisco de Assis Acurcio. (2018) Uso de medicamentos e fatores associados à polifarmácia em indivíduos com diabetes mellitus em Minas Gerais, Brasil. Ciência & Saúde Coletiva 23:8, pages 2565-2574.
Crossref
Alyson Myers, Patricia Garnica & Jason Ling. (2018) Advances in Managing Type 2 Diabetes in the Elderly: A Focus on Inpatient Care and Transitions of Care. American Journal of Therapeutics 25:1, pages e152-e172.
Crossref
A. Z. Fu & J. J. Sheehan. (2016) Treatment intensification for patients with type 2 diabetes and poor glycaemic control. Diabetes, Obesity and Metabolism 18:9, pages 892-898.
Crossref
Danilo D. Trevisan, Juliana B. Silva, Valéria C. Póvoa, Carla P. Araujo, Henrique C. Oliveira, Eliana P Araújo, Silvia R. Secoli & Maria Helena M. Lima. (2015) Prevalence and clinical significance of potential drug-drug interactions in diabetic patients attended in a tertiary care outpatient center, Brazil. International Journal of Diabetes in Developing Countries 36:3, pages 283-289.
Crossref
Marcus May & Christoph Schindler. (2016) Clinically and pharmacologically relevant interactions of antidiabetic drugs. Therapeutic Advances in Endocrinology and Metabolism 7:2, pages 69-83.
Crossref
Rodrigo Fonseca Lima, Alexandre Vaz Machado, Fernanda Maciel Rebelo, Janeth De Oliveira Silva Naves, Tatiana Ramos Lavich & Jane Dullius. (2015) INTERAÇÕES MEDICAMENTOSAS POTENCIAIS EM DIABÉTICOS TIPO 2 PARTICIPANTES DE UM PROGRAMA DE EDUCAÇÃO EM SAÚDE. Infarma - Ciências Farmacêuticas 27:3, pages 160-167.
Crossref
Lawrence A. Leiter, William T. Cefalu, Tjerk W. A. de Bruin, Ingrid Gause‐Nilsson, Jennifer Sugg & Shamik J. Parikh. (2014) Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24‐Week, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study with a 28‐Week Extension. Journal of the American Geriatrics Society 62:7, pages 1252-1262.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.